Peter Martin, M.D., is an Associate Professor of Medicine and Chief of the Lymphoma Program at Weill Cornell Medicine. Dr. Martin completed his residency in internal medicine and fellowship in hematology at McGill University. Prior to joining the faculty at Weill Cornell Medical College, he completed a Master’s Degree in Clinical Investigation and Translational Research at the Weill Cornell School of Graduate Sciences.
Dr. Martin specializes in caring for patients with lymphoma. His research focuses on the clinical investigation of new and promising therapies, and he passionately believes that clinical trials are the gateway to a better future. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the Alliance for Clinical Trials in Oncology. He is board certified in Hematology and Internal Medicine by the American Board of Internal Medicine and the Royal College of Physicians and Surgeons of Canada. He has received awards and funding from the National Cancer Institute, the National Cancer Institute of Canada, the Leukemia and Lymphoma Society, the Lymphoma Research Foundation, the American Society of Hematology, and the American Society for Clinical Oncology for his research.